NCT02305030View on ClinicalTrials.gov

Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Parkinson's Disease

Interventions

DRUG

BIA 9-1067

DRUG

Warfarin

All Listed Sponsors

lead

Bial - Portela C S.A.

INDUSTRY

NCT02305030 - Effect of Opicapone at Steady State on Warfarin Pharmacokinetics | Biotech Hunter | Biotech Hunter